Acoustic Neuroma (Vestibular Schwannoma) - Symptoms, Diagnosis & Treatment | CancerCaree
Expert Medical Team
Global Network
Trusted Information
Multilingual Support

Acoustic Neuroma (Vestibular Schwannoma)

Comprehensive information about Acoustic Neuroma, a benign brain tumor affecting the hearing and balance nerves. Learn about symptoms, diagnosis, and the latest minimally invasive treatment options.

95%
Benign Tumors
90%
Hearing Preservation with Gamma Knife
1 in 100,000
Annual Incidence

Understanding Acoustic Neuroma

Acoustic neuroma is a benign, slow-growing tumor that develops on the eighth cranial nerve, which connects the inner ear to the brain.

Acoustic neuroma, also known as vestibular schwannoma, is a non-cancerous tumor that develops on the vestibulocochlear nerve (eighth cranial nerve). This nerve is responsible for hearing and balance. While these tumors are benign and do not spread to other parts of the body, they can cause serious complications as they grow and press against important brain structures.

Most acoustic neuromas grow slowly, at a rate of about 1-2 mm per year. However, some may grow more rapidly or remain stable in size for years. The symptoms typically develop gradually as the tumor enlarges and puts pressure on the surrounding nerves and brain structures.

Acoustic neuromas account for approximately 6-10% of all intracranial tumors and about 80-90% of tumors in the cerebellopontine angle. They typically occur in adults between the ages of 30 and 60, with a slightly higher incidence in women than men.

In most cases (about 95%), acoustic neuromas occur spontaneously without any known cause. The remaining 5% are associated with a genetic condition called neurofibromatosis type 2 (NF2), which causes tumors to develop on nerves throughout the body.

Acoustic Neuroma Anatomy Illustration

Symptoms and Diagnosis

Recognizing the signs of acoustic neuroma is crucial for early detection and treatment.

Hearing Symptoms

Gradual hearing loss in one ear is the most common symptom of acoustic neuroma, often accompanied by tinnitus (ringing in the ear).

  • Progressive hearing loss in one ear
  • Tinnitus (ringing or buzzing)
  • Difficulty understanding speech
  • Sudden hearing loss in rare cases

Balance Issues

As the tumor affects the vestibular nerve, balance problems and dizziness may occur, especially when the tumor grows larger.

  • Unsteadiness or loss of balance
  • Dizziness or vertigo
  • Difficulty walking in the dark
  • Motion sensitivity

Neurological Symptoms

Larger tumors can press on nearby cranial nerves and brain structures, causing additional symptoms.

  • Facial numbness or tingling
  • Facial weakness or paralysis
  • Headaches
  • Mental confusion in advanced cases

Advanced Treatment Options

Modern approaches to acoustic neuroma treatment have significantly improved patient outcomes with minimal side effects.

Observation
Radiosurgery
Microsurgery
Hearing Preservation

Observation (Watchful Waiting)

For small, asymptomatic tumors or in elderly patients, observation with regular MRI scans may be the preferred approach.

60%
No Growth
5 years
Monitoring Period
85%
Quality of Life

Observation, also known as watchful waiting, is often recommended for small tumors (less than 1.5 cm), tumors in elderly patients, or when the risks of treatment outweigh the benefits. This approach involves regular monitoring with MRI scans, typically every 6-12 months, to track any tumor growth.

Approximately 40-60% of acoustic neuromas show no significant growth over 5 years when managed with observation alone. For tumors that do grow, the growth rate is typically slow (1-2 mm per year), allowing time to intervene with treatment if necessary. This approach preserves hearing and avoids potential treatment complications in many cases.

Stereotactic Radiosurgery

Stereotactic radiosurgery delivers precisely targeted radiation to the tumor while sparing surrounding healthy tissue.

90-95%
Control Rate
70-80%
Hearing Preservation
1 day
Treatment Duration

Stereotactic radiosurgery (SRS), including Gamma Knife and CyberKnife, is a non-invasive treatment that delivers highly focused radiation beams to the tumor. This approach is typically used for small to medium-sized tumors (up to 3 cm) and aims to stop tumor growth while preserving neurological function.

Gamma Knife radiosurgery, developed in 1968, has become the gold standard for acoustic neuroma treatment with over 50,000 patients treated worldwide. The procedure is typically performed in a single session with local anesthesia, and patients can usually return to normal activities within 1-2 days. Long-term control rates exceed 90% with minimal side effects.

Microsurgical Removal

Surgical removal of the tumor may be necessary for large tumors or those causing significant symptoms.

98%
Complete Removal
50-60%
Hearing Preservation
4-6 weeks
Recovery Time

Microsurgical removal is typically recommended for large tumors (greater than 3 cm), tumors causing brainstem compression, or when rapid growth is observed. The three main surgical approaches are:

Retrosigmoid approach: Provides access to the cerebellopontine angle while preserving hearing in selected cases. This is the most versatile approach for tumors of various sizes.

Middle fossa approach: Best for small tumors with serviceable hearing, offering the highest chance of hearing preservation.

Translabyrinthine approach: Used when hearing is already poor, providing direct access to the tumor with lower risk to facial nerve function.

Hearing Preservation Strategies

Modern techniques focus on preserving hearing whenever possible during acoustic neuroma treatment.

70-80%
With Radiosurgery
50-60%
With Middle Fossa Surgery
95%
Facial Nerve Preservation

Hearing preservation is a primary goal in acoustic neuroma treatment, especially for patients with serviceable hearing before treatment. Several factors influence hearing preservation success:

Tumor size: Smaller tumors (less than 1.5 cm) have better hearing preservation outcomes.

Pre-treatment hearing level: Patients with better hearing before treatment are more likely to preserve it.

Treatment approach: Stereotactic radiosurgery generally offers higher hearing preservation rates than microsurgery.

For patients who lose hearing, modern hearing rehabilitation options include contralateral routing of signals (CROS) hearing aids, bone-anchored hearing devices, and auditory brainstem implants for select cases.

World-Class Treatment Centers

Leading hospitals worldwide with specialized expertise in acoustic neuroma treatment.

Mayo Clinic (USA)

World-renowned for multidisciplinary approach to acoustic neuroma, offering all treatment modalities with exceptional outcomes.

Johns Hopkins Hospital (USA)

Pioneers in skull base surgery with one of the largest acoustic neuroma programs in the world.

University of Pittsburgh Medical Center (USA)

Home to the world's first Gamma Knife center with unparalleled experience in radiosurgery for acoustic neuroma.

Beijing Tiantan Hospital (China)

Leading center for acoustic neuroma treatment in Asia with advanced microsurgical and radiosurgical capabilities.

Clinical Trials in China

Access to cutting-edge acoustic neuroma treatments through clinical trials available in China.

Hearing Preservation with Fractionated Radiosurgery

Shanghai Gamma Knife Center

Phase II clinical trial evaluating the efficacy of fractionated Gamma Knife radiosurgery for hearing preservation in patients with small to medium-sized acoustic neuromas.

Recruiting

Facial Nerve Monitoring During Surgery

Beijing Neurosurgical Institute

Randomized controlled trial comparing outcomes with continuous intraoperative facial nerve monitoring versus standard intermittent monitoring during acoustic neuroma surgery.

Recruiting

Quality of Life After Treatment

Huashan Hospital, Shanghai

Prospective observational study evaluating long-term quality of life outcomes in patients treated with microsurgery versus radiosurgery for acoustic neuroma.

Recruiting

Ready to Explore Your Treatment Options?

Contact our specialists to discuss advanced acoustic neuroma treatments available worldwide, including access to clinical trials and cutting-edge therapies.